AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Luliza 1% Lotion

Prescription Icon
Prescription Required

Marketer

Anhox Healthcare Pvt Ltd

Salt Composition

Luliconazole (1% w/v)

Overview Luliza 1% Lotion

DermaClear 1% Lotion, an antifungal medication, effectively combats various skin fungal infections including athlete's foot, tinea cruris, candidiasis, tinea corporis, and xerosis. Its mechanism involves eliminating the causative fungi. Adhere strictly to your physician's prescribed dosage and duration; exceeding it won't hasten recovery and may heighten adverse effects. Most skin infections resolve within 2-4 weeks. Report any lack of improvement to your doctor. Maintaining cleanliness and dryness of the affected area, along with hand washing before and after application, enhances efficacy. For athlete's foot, ensure thorough sock/stocking cleaning and daily shoe changes if feasible. Common, typically transient side effects include application site burning, irritation, itching, redness, and dryness. Persistent or bothersome effects warrant medical consultation. Seek immediate medical attention for allergic reactions (rash, lip/throat/face swelling, breathing/swallowing difficulties, nausea). Avoid eye contact; rinse immediately with water and seek medical help if accidental contact occurs. While unlikely, inform your doctor about concurrent oral or injectable medications, especially recent steroid use or prior antifungal allergy. Pregnant or breastfeeding individuals should consult their doctor before use.

Uses of Luliza 1% Lotion

Managing cutaneous mycoses

Major Benefits of Luliza 1% Lotion:

Apply this medication topically only. Follow your doctor's instructions precisely regarding dosage and treatment length. Ensure thorough shaking before applying a uniform layer to the affected region.

Common Side effects of Luliza 1% Lotion:

  • Application site reactions (burning, irritation, itching and redness)
  • Dry skin

How to use Luliza 1% Lotion:

Apply this medication only to the skin's surface. Follow your doctor's instructions precisely regarding dosage and treatment length. Ensure thorough mixing before applying a uniform layer to the affected region.

How Luliza 1% Lotion works:

Dermaclear 1% topical solution is an antifungal agent indicated for cutaneous fungal infections. Its mechanism of action involves disruption of the fungal cell wall, thereby alleviating associated skin symptoms such as itching, burning, and inflammation.

SAFETY ADVICE

AlcoholAlcoholNone

No known drug interactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Luliza 1% Lotion during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the unborn child. A physician will assess the potential advantages against any risks prior to recommending its use. Seek medical advice before using this lotion.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Application of Luliza 1% Lotion while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingNone

No drug interactions identified.

KidneyKidneyNone

No drug interaction detected.

LiverLiverNone

No drug interaction detected.

What if you forget to take Luliza 1% Lotion :

Should you forget to apply Luliza 1% Lotion, apply it at your earliest convenience. Nevertheless, if your next application is imminent, omit the missed application and resume your usual dosing regimen. Avoid applying a double dose.

Facts to Know About Luliza 1% Lotion

LabelValue
Type of Compound Imidazole-containing compounds
Potential for Dependence None.
Type of Medication CUTANEOUS

FAQs on Luliza 1% Lotion

The use of Luliza 1% Lotion is not recommended during pregnancy due to a lack of safety data. Nevertheless, a physician should be consulted to weigh the potential benefits against any risks to the fetus should the lotion's application be deemed necessary.
Luliza 1% Lotion possesses antifungal properties by inhibiting fungal growth. This action stems from its reduction of ergosterol, a crucial component of the fungal cell membrane, thus demonstrating its fungicidal effect.
Apply Luliza 1% Lotion precisely as directed by your physician. For athlete's foot affecting the spaces between your toes, apply a thin coating to the infected area, extending the application at least one inch beyond the affected zone. Apply once daily for a fortnight. For jock itch or ringworm, apply a thin layer to the affected skin, extending the application one inch beyond the affected area. Apply once daily for seven days. Wash your hands thoroughly after each application.
Luliza 1% Lotion shows varying efficacy depending on the condition. Athlete's foot treatment between the toes usually demonstrates improvement within four weeks, though a six-week timeframe may be necessary for some individuals. In contrast, jock itch and ringworm typically show improvement within three weeks, with a potential extension to four weeks in certain cases.
Store Luliza 1% Lotion in its original container, tightly sealed, and inaccessible to children. Maintain storage at room temperature (20°C to 25°C), shielded from light, excessive heat, and dampness; avoid bathroom storage.
Utilizing Luliza 1% Lotion in children over two years old is confirmed safe and efficacious. Studies indicate comparable safety and efficacy profiles in both pediatric and adult populations.
Luliza 1% Lotion
164
MRP 200
18% off